|
contents | europe | ||||
| BIO-Europe 2007 The leaders of the biotechnology industry will once again gather for BIO-Europe, the world's largest stand-alone partnering conference, in Hamburg, Germany (November 12-14). This year's edition promises to set a new standard for compelling and informative content necessary to discern opportunities in an era of significant biotech industry change. Join many of the most respected thought leaders and decision makers in the industry and examine the issues, new business approaches and policy trends most important to the emerging biotech future. A central theme to BIO-Europe 2007 will be to understand the signs, symptoms and opportunities of the much-anticipated convergence of biotech and Big Pharma. Fundamental questions, such as how can biotechnology companies help the pharmaceutical industry meet double digit growth expectations by contributing new products and processes, will be openly discussed and debated by some of the most notable names in the industry. A session destined to shake up traditional wisdom and preconceived notions of the industry is entitled, "The Changing World Order of Biotech-Pharma – How Will Emerging Realities Affect Your Business Strategy?" Other conference highlights include the not to be missed 5th annual "A Day in the Life of Experienced Dealmakers" Plenary Session. Led by James Watson, Managing Director and Head of Merchant Banking, Burrill & Company and including industry notables as Thomas Hofstaetter, Senior Vice President of Corporate Development, Wyeth and John G. Goddard, Global Head and Senior VP of Strategic Planning and Business Development, AstraZeneca, this highly popular and provocative forum promises to continue its tradition of lively and insightful debate over key issues of strategic deal making by some of the biggest names in biotech deal making. write your comments about the article :: © 2007 Exhibition News :: home page |